Used primarily as an intermediate in the synthesis of pharmaceuticals, particularly in the development of central nervous system agents. Its structure supports the creation of bioactive molecules due to the presence of both amine and ether functional groups, which enhance binding affinity and solubility in drug compounds. Commonly employed in the preparation of analgesics and neuroactive drugs, where the tetrahydropyran ring contributes to metabolic stability and the aminomethyl group enables salt formation for improved pharmacokinetics. Also utilized in medicinal chemistry research for scaffold modification and library generation in drug discovery.